SIGHT
vs
AMGN
SIGHT
AMGN
Over the past 12 months, SIGHT has underperformed AMGN, delivering a return of -74% compared to the AMGN's +20% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
SIGHT
AMGN
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Gensight Biologics SA
PAR:SIGHT
|
0.0804
EUR
|
|||||
|
Amgen Inc
NASDAQ:AMGN
|
342.22
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
SIGHT, AMGN
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
Gensight Biologics SA
Revenue
|
|||||||||||
|
Amgen Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
SIGHT, AMGN
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
Gensight Biologics SA
PAR:SIGHT
|
|||||||||
|
Amgen Inc
NASDAQ:AMGN
|
|||||||||
Compare company's free cash flow with its competitors.
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Gensight Biologics SA | ||||
|
Amgen Inc | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
SIGHT, AMGN
Performance Gap
SIGHT, AMGN
Performance By Year
SIGHT, AMGN
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.